A	B	C	D	E	F	G	H	I	J	K	L	M
1	Main
2	Failures
3		Brand Name	Generic Name		Indication	Mechanism	Approval	Revenue
4		Arthrotec						300m
5		Celebrex	celecoxib		Arthritis	COX-2	12/31/1998
6		Cleocin				macrolide		175m
7		Covera HS
8		Estring
9		Fablyn
10		Gelfilm
11		Lyrica	pregabalin		Epilepsy, Pain, FMS	GABA delta ligand	12/30/2014
12
13
14		Brand Name	Generic Name	Status	Indication	Mechanism	Phase	Results
15		PD-332,334
16		S,S-reboxetine
17			torcetrapib
18		Exubera
19		PEG HGH?
20		CP-607,366
21		PNU-108112
22		PNU-93914
23		VIC-ACNE
24
25		Edotecarin
26		Camptosar
27		CP-751,871
28		PF-514273
29		CE-326597
30		PF-3185043
31		CP-800569
32		PF-3392455
33		PF-277343
34		PF-04548043/KOS-2187
35		CP-424,391 (capromorelin)
36		PF-885706
37		PF-708093
38		PF-4522625
39		PF-572778
40		PF-477736
41		PF-3814735
42		PF-562271
43		CVX-045
44		PF-337210
45		PF-3,732,010
46		PF-04217903
47		UK 396082
48		SNX5422/PF-04929113
49		CP-870893
50		PF-3557156
51		CP-601927
52		PF-3463275
53		PF-2400013
54		CP-903397
55		PF-04447943
56		PF-592379
57		PF-04191834
58		PF-4136309
59		PF-4480682
60		PF-4523655
61		AG-13958
62		CP-675206
63		SU-14813
64		PF-1367338/AG-014699
65		PF-4494700
66		CP-448187 (elzasonan)
67		PD-200,390
68		PD-299,685
69		PF-04360365	ponezumab
70		PF-232798
71		UK-369003
72		PF-217830
73		PF-03654746
74		PF-3491390
75		UK-157147
76		PF-275366
77		PH-794428
78		CP-533536
79		PF-610355
80		UK-453061 (lersivirine)
81
82		Withdrawn/Failed
83		Figitumumab
84		Tanezumab
85		Torcetrapib
86		Rezulin
87		Trovan
88		Bextra - suspended in 2005. Peaked at $1.3bn.
89		SU-6888
90		cdk2/cdk4
91		AG-2037
92		CJ-23,423
93		VIC-5555
94		Thelin
95		SU-14,813
96		PF-00708093 oxazolidinone
97		UK-464,273
98		canertinib/CI-1033
99		CI-1040 (MEK)
100		FGF-14
101		CI-994 (HDAC)
102		Pleiotropin
103		Gemcabene/CI-1027
104		CP-122,721 (Substance P)
105		BAY-74-4113 (DGAT)
106		AG-1859 (Protease Inhibitor for HIV)
107		CP-866,087
108		AMF antibody (autocrine motility factor)
109		Alpha-5-beta integrin
110		PF-190,424 (cardiology)
111		PF-489,781 (HTN)
112		begacestat
113		sulopenem
114		CE-224,535
115		bapineuzumab
116		Aprela (bazedoxifene+estrogen)	Menopause	Estrogen	LGND	III
117		PF-00299804 (dacomitinib)	NSCLC	Pan-HER	1	III	Tykerb, Herceptin		9/30/2008 advanced
118		PF-03882845	Diabetic Nephropathy	Mineralocorticoid antagonist	1	I
119		PF-05231023	Type 2 Diabetes	Undisclosed	1	I
120		PF-05190457	Type 2 Diabetes	Ghrelin	1	I
121		CVX-096 (PF-04856883)	Type 2 Diabetes	GLP1	1	I
122		OAP-189 (PF-05212389)	Type 2 Diabetes	Oxyntomodulin	1	I	Biologic. Previously listed as GLP1?
123		PF-04991532	Type 2 Diabetes	Unknown	1	II
124		PF-868554 (filibuvir)	Hepatitis C	Polymerase	1	II	Roche	Oral	Disclosed 7/31/2007
125		IMA-638 (anrukinzumab)	Ulcerative Colitis	IL-13 Antibody	1	II			Discontinued 11/8/13
126		PF-03049423	Stroke Recovery	PDE5	1	II			Discontinued 11/8/13
127		PF-04691502	Cancer	mTOR/PI3K	1	II	NVGN, ARIA, NVS
128		PF-04856884/CVX-060	Cancer	Ang2	1	II							Failures
129		PF-05236806/ACC-001	Alzheimer's	A-Beta Vaccine	1	II
130		PF-04382923	AMD	Undisclosed	1	I
131		PF-04605412	Cancer	Integrin	1	I
132		PF-04531083	Pain	Undisclosed	1	I
133		PF-04427429	Migraine	CGRP Antibody	1	I
134		PF-05180999	Schizophrenia		1	I
135		RN317/PF-05335810	Dyslipidemia
136		PF-06305591	Pain	I
137		Remoxy	Pain	Opioid	PTIE	Filed	Purdue?
138		tanezumab	Pain	NGF Antibody	1	III			2/28/14 Updated
139		PH-797804	COPD	p38	1	II		Oral	2/28/14 Updated
140		bococizumab RN316 (PF-04950615)	Hypercholesterolemia	PCSK9	1	III		SQ	2/28/14 Updated
141		PD-0360324	Sarcoidosis, Lupus	MCSF Mab	1	II			2/28/14 Updated
142		PF-00547659 (ontamalimab)	Crohn's, Ulcerative Colitis	MadCAM Antibody	1	II			2/28/14 Updated	Divested to Takeda
143		PF-06290510	Staph Aureus	Vaccine	1	II			2/28/14 Updated
144		PF-02545920	Schizophrenia	PDE10A	1	II			2/28/14 Updated
145		PF-04236921	Crohn's, Lupus	IL-6 Antibody	1	II			2/28/14 Updated
146		PF-05285401	Ulcerative Colitis	Multistem	ATHX	II			2/28/14 Updated
147		PF-06473871 (EXC-001)	Dermal Scarring	CTGF	1	II	Acquired from Excalliard. Phase II reported?		2/28/14 Updated
148		PF-04171327	RA	GR agonist	1	II			2/28/14 Updated
149		PF-04937319	Type 2 Diabetes	Glucokinase	1	II			2/28/14 Updated
150		PF-05175157	Type 2 Diabetes	Acetyl-CoA carboxylase	1	II			2/28/14 Updated
151		PF-04634817	Diabetic Nephropathy	CCR2/5	1	II			2/28/14 Updated
152		PF-00489791	Diabetic Nephropathy	PDE5	1	II	Positive POC, was HTN/PAH.		2/28/14 Updated
153		PF-04360365 (ponezumab)	Cerebral Amyloid Angiopathy	Beta Amyloid	1	II			2/28/14 Updated
154		PF-05212384	Cancer	mTOR/PI3K	1	II			2/28/14 Updated
155		PF-03446962	Cancer	ALK1 mab	1	II			2/28/14 Updated
156		PF-05089771	Pain	Nav1.7	1	I			2/28/14 Updated
157		PD-0325901	Cancer	MEK	1	I			2/28/14 Updated
158		Dekavil	RA		Philogen	I			2/28/14 Updated
159		PF-05230907	Intracerebral Hemorrhage	Biologic	1	I			2/28/14 Updated
160		PF-05082566	Cancer	4-1BB	1	I			2/28/14 Updated
161		PF-06687859	SMA	Decapping Enzyme	Repligen	I			2/28/14 Updated
162		PF-06252616	Muscular Dystrophy	Myostatin	1	I			2/28/14 Updated
163		PF-05280602	Hemophilia	Biologic	1	I			2/28/14 Updated
164		PF-03715455	COPD	Undisclosed	1	I			2/28/14 Updated
165		PF-05402536	Smoking Cessation		1	I			2/28/14 Updated
166		PF-06425090	C. Difficile		1	I			2/28/14 Updated
167		PF-06263276	Psoriasis		1	I			2/28/14 Updated
168		PF-06263507	Cancer		1	I			2/28/14 Updated
169		PF-06444752	Asthma	IGGE Vaccine	1	I			2/28/14 Updated
170		PF-06480605	Crohn's		1	I			2/28/14 Updated
171		PF-06342674	Type 1 Diabetes		1	I			2/28/14 Updated
172		PF-04958242	Schizophrenia	AMPA	1	I			2/28/14 Updated
173		PF-05212377 (SAM-760)	Alzheimer's	5HT6	1	I			2/28/14 Updated
174		PF-06649751	Parkinson		1	I			2/28/14 Updated
175		PF-06372865	Pain		1	I			2/28/14 Updated
176		PF-06273340	Pain		1	I			2/28/14 Updated
177		PF-05236812 (AAB-003)	Alzheimer's	Abeta Vaccine	1	I			2/28/14 Updated
178		PF-06291874	Type 2 Diabetes		1	I			2/28/14 Updated
179		PF-06282999	ACS		1	I			2/28/14 Updated
180		PF-06678552	Hypercholesterolemia		1	I			2/28/14 Updated
181		PF-06438179	Rheumatoid Arthritis	Biosimilar Remicade	1	I			2/28/14 Updated
182		PF-03084014	Cancer	Gamma Secretase	1	I			2/28/14 Updated